跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37 条关于
“Viracor”
全部
37
临床试验
17
药物
3
机构
6
资讯
11
5个月前
Eurofins Viracor Launches Rapid CAR T-Cell Monitoring Assay for Obe-cel Therapy
去年
Eurofins Viracor BioPharma Expands Operations with New 96,000 Sq. Ft. State-of-the-Art Facility
去年
Viracta Therapeutics Halts Lymphoma Trial, Explores Strategic Options Amid Financial Constraints
去年
BiVACOR Total Artificial Heart Study Expanded After Successful Initial Implants
去年
FDA Approves Phase 2 Trial of Revolutionary BiVACOR Artificial Heart Device
去年
Viracta Therapeutics' Nana-Val Shows Promise in Post-Transplant Lymphoproliferative Disorder
去年
Neuralink to Begin Canadian Clinical Trial; 23andMe Partners with Mirador Therapeutics
去年
Christ Hospital Surgeons Implant Bivacor Total Artificial Heart as Bridge to Transplant
去年
Australian Man Survives 100 Days with BiVACOR Artificial Titanium Heart in Groundbreaking Trial
2个月前
Mirador Therapeutics Licenses KP-301, a Long-Acting Anti-C5a Antibody, Expanding into ANCA-Associated Vasculitis
第 1 页,共 2 页
上一页
下一页